NASDAQ : INCR
InterCure Ltd. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · Israel
Last price 3.97 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 51.59M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 51.59M |
| Enterprise Value | 94.91M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 11.85M |
| Shares Outstanding | 10.94M |
| Shares Change (YoY) | +17.17% |
| Shares Change (QoQ) | -10.76% |
| Owned by Insiders (%) | 39.17% |
| Owned by Institutions (%) | 2.88% |
| Float | 7.21M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.61 |
| Forward PS | n/a |
| PB Ratio | 0.41 |
| P/TBV Ratio | 0.93 |
| P/FCF Ratio | 12.21 |
| P/OCF Ratio | 9.63 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 22.45 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.48 |
| Quick Ratio | 0.91 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | n/a |
| Debt / FCF | 13.58 |
| Interest Coverage | -3.42 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -9.27% |
| Return on Assets (ROA) | -5.78% |
| Return on Invested Capital (ROIC) | -12.62% |
| Return on Capital Employed (ROCE) | -14.12% |
| Weighted Average Cost of Capital (WACC) | 8.14% |
| Revenue Per Employee | $297,387 |
| Profits Per Employee | -$39,303 |
| Employee Count | 285 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 2.01 |
Taxes
| Measure | Value |
|---|
| Income Tax | -2.30M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -42.88% |
| 50-Day Moving Average | 5.08 |
| 200-Day Moving Average | 4.62 |
| Relative Strength Index (RSI) | 29.18 |
| Average Volume (20 Days) | 4,807 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4,410 |
| Short Previous Month | 4,549 |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.06% |
| Short Ratio (days to cover) | 0.95 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 84.76M |
| Gross Profit | 12.77M |
| Operating Income | -21.09M |
| Pretax Income | -13.83M |
| Net Income | -11.20M |
| EBITDA | -17.36M |
| EBIT | -21.09M |
| Loss Per Share | -$1.06 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 14.64M |
| Total Debt | 57.41M |
| Net Cash | -42.77M |
| Net Cash Per Share | -$3.91 |
| Equity (Book Value) | 124.33M |
| Book Value Per Share | 11.37 |
| Working Capital | 32.11M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 5.36M |
| Capital Expenditures | -1.13M |
| Depreciation & Amortization | 3.78M |
| Net Borrowing | -9.26M |
| Free Cash Flow | 4.23M |
| FCF Per Share | $0.39 |
Margins
| Measure | Value |
|---|
| Gross Margin | 15.06% |
| Operating Margin | -24.89% |
| Pretax Margin | -16.32% |
| Profit Margin | -13.22% |
| EBITDA Margin | -20.48% |
| EBIT Margin | -24.89% |
| FCF Margin | 4.92% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -17.17% |
| Shareholder Yield | n/a |
| Earnings Yield | -26.61% |
| FCF Yield | 8.19% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 24, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.15 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |